*By Carlo Versano* The bull run in cannabis stocks is "absolutely not" sustainable and is headed for a retrenchment, said Matt Karnes, founder of GreenWave Advisors, a research firm that specializes in the budding legal pot industry. Shares of companies like Canopy Growth, Tilray, and Cronos Group ー all based in Canada ー have seen double-digit gains in the past week. Marijuana stocks have been caught up in a flurry of deal-making, partnerships, and acquisitions as the industry gains legitimacy. Investors have been reacting to each new headline with knee-jerk enthusiasm, Karnes said. [Constellation Brands' investment in Canopy](https://cheddar.com/videos/corona-brewer-adds-cannabis-to-its-booze-business-in-4-billion-deal) is one example ー news of the deal sent shares of the target company up 30 percent ー but Karnes doesn't think the enthusiasm can continue at the same clip. "The excitement comes from the potential of the marketplace, and we're nowhere near seeing what that marketplace looks like," he said in an interview with Cheddar Tuesday. "Let's see what sticks to the wall." Companies that make a lot of money off beer sales, which are trending down, seem like natural suitors for cannabis makers, he said. Those are smart, defensive plays. But Karnes remains skeptical that these big beverage brands can refashion themselves as pharmaceutical companies by trying to enter the medical marijuana market. He is bullish on cannabis long-term, though ー so much so, that he started his own research firm just for the sector. Marijuana is set to become legal for adult recreational use in Canada this October. Karnes said it's an exciting moment for anyone invested in the growth of the cannabis industry, but it's still crucial to apply due diligence ー and not just buy on the rampant speculation. He also said recreational and medical cannabis should be combined into a single sector that can be regulated by one authority. "It's basically the same product, for all intents and purposes." For full interview [click here](https://cheddar.com/videos/why-marijuana-stocks-are-soaring).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More